Detalhe da pesquisa
1.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733229
2.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384247
3.
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study).
Hematol Oncol
; 40(4): 609-616, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612350
4.
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
Hematol Oncol
; 38(4): 478-486, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542788
5.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653509
6.
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv
; 7(15): 4160-4169, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276080
7.
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement.
Front Immunol
; 13: 934700, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911683
8.
Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas.
Cancer Manag Res
; 14: 3205-3221, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444356
9.
High grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma.
Leuk Lymphoma
; 63(6): 1356-1362, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045798
10.
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy.
Hemasphere
; 6(12): e798, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398133
11.
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.
J Clin Oncol
; 39(11): 1214-1222, 2021 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577377
12.
Treatment of very high-risk classical Hodgkin Lymphoma: cases' selection from real life and critical review of the literature.
Acta Biomed
; 91(S-5): 13-22, 2020 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525130
13.
Polatuzumab-bendamustine-rituximab as bridge to CD19-directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax.
EJHaem
; 4(2): 559-562, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37206291
14.
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.
Leuk Res
; 104: 106552, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689920
15.
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.
J Clin Oncol
; 34(33): 4015-4022, 2016 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199143
16.
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL).
Hemasphere
; 3(6): e305, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31976479